Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.920 | 0.950 | 0.030 |
Shares | 99.090 | 99.090 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21.976 | 21.195 |
Price to Book | 4.489 | 4.173 |
Price to Sales | 2.339 | 2.490 |
Price to Cash Flow | 20.179 | 17.334 |
Dividend Yield | 1.368 | 1.320 |
5 Years Earnings Growth | 11.089 | 13.721 |
Number of long holdings: 51
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 7.26 | 750.9 | +4.03% | |
AstraZeneca | GB0009895292 | 6.30 | 10,474.0 | +4.10% | |
J&J | US4781601046 | 6.21 | 154.76 | -0.48% | |
Roche Holding Participation | CH0012032048 | 5.91 | 254.30 | +1.27% | |
Eli Lilly | US5324571083 | 5.43 | 745.97 | -0.53% | |
Lonza Group | CH0013841017 | 4.58 | 521.40 | -0.04% | |
Thermo Fisher Scientific | US8835561023 | 4.28 | 512.99 | -0.60% | |
AbbVie | US00287Y1091 | 3.69 | 177.31 | +3.25% | |
UnitedHealth | US91324P1021 | 3.40 | 590.46 | -1.18% | |
Pfizer | US7170811035 | 2.88 | 25.59 | +1.81% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DNB Global indeks NOK | 117.02B | 26.57 | 16.11 | 15.16 | ||
DNB Teknologi NOK | 78.7B | 28.90 | 18.52 | 23.90 | ||
NO0010801913 | 75.2B | 24.89 | 17.50 | 23.61 | ||
Pensjonsprofil 80 | 50.55B | 14.72 | 6.37 | 8.76 | ||
DNB Global IV | 41.13B | 23.11 | 16.22 | 15.95 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review